Head-to-head clinical evidence SURPASS-2: Mounjaro vs Ozempic in type 2 diabetes The SURPASS-2 trial, published in the New England Journal of Medicine, directly compared tirzepatide with semaglutide 1 mg (the standard Ozempic dose) in 1,879 people with type 2 diabetes over 40 weeks
The New York physician who designed the intervention, Tro Kalayjian, achieved and sustained a 150-pound weight loss with ketogenic therapy
Honest Health History Submission When you talk to your doctor about weight loss injections, be completely open about your medical history
Who is a good candidate for Sleep & Sculpt
Injection technique, timing, and site rotation all matter
It happens when the muscles in the stomach and digestive tract do not contract as strongly as they should, leaving food in the stomach and intestines rather than moving it through the digestive system at a normal pace